Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene
NACompletedINTERVENTIONAL
Enrollment
79
Participants
Timeline
Start Date
October 31, 2007
Primary Completion Date
July 6, 2018
Study Completion Date
July 6, 2018
Conditions
Pharmacokinetics
Interventions
DRUG
escitalopram
escitalopram 4 mg
Trial Locations (1)
81667
Max Planck Institute of Psychiatry, Munich
All Listed Sponsors
lead
Max-Planck-Institute of Psychiatry
OTHER
NCT00550485 - Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene | Biotech Hunter | Biotech Hunter